There appears to be an increased risk of the skin disease rosacea among female migraine sufferers according to a recent study published in the Journal of the American Academy of Dermatology.
Rosacea is a common skin disease associated with skin inflammation and certain vascular changes.
Using the UK –based General Practice Research Database, Julia Spoendlin and colleagues from the University of Basel, identified patients with incident rosacea between 1995 and 2009. (cases; 53,927 participants) and matched rosacea-free control subjects (matched 1:1; 53,927 participants).
The researchers observed a small overall association between rosacea and migraine in women (adjusted odds ratio [aOR], 1.22), but not in men.
In female migraine sufferers aged 50–59 years, the effect was more pronounced (aOR, 1.36). Female triptan users also exhibited slightly increasing risk estimates with increasing age, with the highest odds ratio seen in women aged sixty or older (aOR, 1.66).
“We observed a slightly increased risk for female migraineurs to develop rosacea, particularly in women with severe migraine aged 50 years or older,” the study authors wrote.